Putnam Investments’s Omnicell OMCL Stock Holding History

Putnam Investments’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-46,208	Closed	-$4.02M	–	1176
2022 Q3	$4.02M	Sell	46,208 -18,335	-28%	-$1.93M	0.01%	486
2022 Q2	$7.34M	Buy	64,543 +942	+1%	+$108K	0.01%	359
2022 Q1	$8.24M	Buy	63,601 +37,216	+141%	+$5.36M	0.01%	384
2021 Q4	$4.76M	Buy	+26,385	New	+$4.58M	0.01%	554

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Putnam Investments's OMCL Position: Q4 2022 in Review

Putnam Investments sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 46,208 shares — an estimated $4.02M sold.

Putnam Investments first reported a position in OMCL in Q4 2021 and held it in 4 quarters. The position peaked at $8.24M in Q1 2022. 328 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

Putnam Investments reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
Putnam Investments sold 46,208 Omnicell shares in Q4 2022, an estimated $4.02M.
Putnam Investments first reported a position in Omnicell in Q4 2021 and held it in 4 quarters.
Putnam Investments's Omnicell position peaked at $8.24M in Q1 2022.
328 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.